Cipla to launch Entecavir tablet in USA
Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]
Month: December 2016
DRL launches nystatin and triamcinolone acetonide cream in USA
Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream USP, in the United States market which has been approved by the USFDA. The […]
Alembic Pharma receives USFDA approval for Zolmitriptan
Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American market. The product is therapeutically […]